Security Snapshot

TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) Institutional Ownership

CUSIP: 875372203

13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

273

Shares (Excl. Options)

78,656,848

Price

$19.17

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+4,610,742
Value change
+$81,604,146
Number of holders
273
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
68,947,349
SEC-reported price per share
$19.42
Insider filing price
$19.42
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share is tracked under CUSIP 875372203.
  • 273 institutions reported positions in Q1 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 268 to 273 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $1,645,564,444 to $1,508,280,672.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 273 institutions filings for Q1 2026.

Open SEC evidence

Security key

875372203

Latest holder period

Q1 2026

13F holders

273

13D/G owners

6

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
TNDM
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% $176,563,735 10,106,682 BlackRock, Inc. 31 Mar 2025
Sessa Capital (Master), L.P. 6.7% $78,026,383 4,466,307 Sessa Capital (Master), L.P. 31 Mar 2025
Voya Financial, Inc. 6.3% $79,402,525 4,343,683 Voya Financial, Inc. 31 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC 5.9% $77,682,093 4,052,274 Vanguard Portfolio Management 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.2% $68,125,809 3,553,772 Vanguard Capital Management 31 Mar 2026
ArrowMark Colorado Holdings LLC 4.3% -24% $62,272,841 -$17,272,476 2,889,691 -22% ArrowMark Colorado Holdings, LLC 31 Dec 2025

As of 31 Mar 2026, 273 institutional investors reported holding 78,656,848 shares of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM). This represents 114% of the company’s total 68,947,349 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
85%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 10,690,844 -4.1% 0% $204,943,480
Sessa Capital IM, L.P. 6.9% 4,730,757 -5.4% 1.7% $90,688,612
VANGUARD PORTFOLIO MANAGEMENT LLC 5.8% 3,993,333 0% 0% $76,552,194
ArrowMark Colorado Holdings LLC 4.5% 3,103,609 +7.4% 1.6% $59,496,185
VANGUARD CAPITAL MANAGEMENT LLC 4.4% 3,038,919 0% 0% $58,256,077
GW&K Investment Management, LLC 3.9% 2,689,106 +0.52% 0.45% $51,550,000
STATE STREET CORP 3.9% 2,662,260 +0.78% 0% $51,035,524
Driehaus Capital Management LLC 3.3% 2,304,414 +43% 0.32% $44,175,616
GOLDMAN SACHS GROUP INC 3.2% 2,218,922 +32% 0.01% $42,536,734
CITADEL ADVISORS LLC 3.2% 2,192,667 +5% 0.03% $42,033,426
UBS Group AG 3% 2,047,801 +390% 0.01% $39,256,344
Paradice Investment Management LLC 3% 2,042,425 -1.7% 7.4% $39,153,287
TWO SIGMA INVESTMENTS, LP 2.7% 1,864,194 +55% 0.03% $35,736,599
GEODE CAPITAL MANAGEMENT, LLC 2.4% 1,679,863 +1.8% 0% $32,209,339
JENNISON ASSOCIATES LLC 2.4% 1,658,448 -18% 0.02% $31,792,448
JACOBS LEVY EQUITY MANAGEMENT, INC 2.2% 1,523,946 -7.8% 0.12% $29,214,045
MARSHALL WACE, LLP 2.1% 1,442,472 +65% 0.03% $27,652,189
MORGAN STANLEY 2% 1,357,542 -35% 0% $26,024,095
Freestone Grove Partners LP 1.9% 1,330,742 -7.8% 0.18% $25,510,324
First Light Asset Management, LLC 1.9% 1,314,715 +21% 2.3% $25,203,087
BAILLIE GIFFORD & CO 1.6% 1,089,393 -4.9% 0.02% $20,883,664
WELLINGTON MANAGEMENT GROUP LLP 1.5% 1,042,764 +961% 0% $19,989,786
VOYA INVESTMENT MANAGEMENT LLC 1.2% 804,137 +152% 0.02% $15,415,306
D. E. Shaw & Co., Inc. 1.1% 783,906 -8.2% 0.01% $15,027,478
Soleus Capital Management, L.P. 1.1% 783,000 0.61% $15,010,110

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
37
Latest
Q1 2026
Rows shown
1-25 of 37
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 78,656,848 $1,508,280,672 +$81,604,146 $19.17 273
2025 Q4 74,868,421 $1,645,564,444 +$37,201,810 $21.98 268
2025 Q3 75,062,169 $911,087,579 -$138,652,756 $12.14 251
2025 Q2 80,970,548 $1,506,919,626 +$146,515,993 $18.64 269
2025 Q1 73,028,420 $1,399,471,204 -$74,262,859 $19.16 271
2024 Q4 72,082,680 $2,596,593,509 -$54,203,387 $36.02 311
2024 Q3 73,070,303 $3,098,544,283 -$23,063,732 $42.41 326
2024 Q2 73,624,715 $2,966,330,226 -$12,633,640 $40.29 315
2024 Q1 74,163,562 $2,626,695,815 +$150,901,685 $35.41 290
2023 Q4 70,841,842 $2,095,507,190 +$47,113,352 $29.58 264
2023 Q3 69,587,644 $1,445,242,152 +$40,169,385 $20.77 224
2023 Q2 67,061,755 $1,645,737,206 -$59,226,945 $24.54 242
2023 Q1 68,103,120 $2,765,613,824 +$144,781,126 $40.61 270
2022 Q4 64,356,332 $2,890,283,528 +$83,553,842 $44.95 290
2022 Q3 62,774,623 $3,005,075,951 -$3,660,996 $47.85 279
2022 Q2 61,447,968 $3,637,020,281 -$76,699,636 $59.19 317
2022 Q1 59,516,284 $6,922,056,028 -$138,240,750 $116.29 365
2021 Q4 60,391,589 $9,087,447,171 -$2,104,121 $150.52 376
2021 Q3 61,294,210 $7,318,019,845 +$274,585,725 $119.38 331
2021 Q2 59,035,893 $5,750,025,560 +$205,481,616 $97.40 295
2021 Q1 57,554,702 $5,079,400,953 -$46,897,671 $88.25 282
2020 Q4 58,469,670 $5,594,436,203 +$259,885,627 $95.68 295
2020 Q3 54,610,664 $6,195,906,490 -$74,521,157 $113.50 317
2020 Q2 55,340,731 $5,467,195,169 +$30,463,584 $98.92 298
2020 Q1 55,943,514 $3,597,678,709 +$179,201,893 $64.35 272
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .